sarcoidosis associated pulmonary hypertension
Showing 1 - 25 of >10,000
Sarcoidosis-associated Pulmonary Hypertension Trial in Worldwide (Selexipag, Placebo)
Active, not recruiting
- Sarcoidosis-associated Pulmonary Hypertension
- Selexipag
- Placebo
-
Indianapolis, Indiana
- +38 more
Jan 31, 2023
Sarcoidosis, Precapillary Pulmonary Hypertension, Interstitial Lung Disease Trial in Gainesville (Inhaled Treprostinil)
Recruiting
- Sarcoidosis
- +2 more
- Inhaled Treprostinil
-
Gainesville, FloridaUniversity of Florida, Division of Pulmonary and Critical Care M
Nov 12, 2021
Pulmonary Arterial Hypertension, Pulmonary Hypertension, Interstitial Lung Disease Trial in Germany, United States (Bardoxolone
Completed
- Pulmonary Arterial Hypertension
- +11 more
- Bardoxolone methyl
- Placebo
-
Phoenix, Arizona
- +31 more
Nov 12, 2021
Obesity, Interstitial Lung Disease, COPD Trial (Semaglutide Pen Injector)
Not yet recruiting
- Obesity
- +4 more
- Semaglutide Pen Injector
- (no location specified)
Feb 15, 2023
Pulmonary Hypertension, Heart Failure Trial (Pulmonary Artery Denervation)
Not yet recruiting
- Pulmonary Hypertension
- Heart Failure
- Pulmonary Artery Denervation
- (no location specified)
Aug 13, 2023
Chronic Thromboembolic Pulmonary Hypertension
Recruiting
- Chronic Thromboembolic Pulmonary Hypertension
- blood sample
-
Saint-Étienne, FranceCHU de SAINT-ETIENNE
Nov 14, 2022
Pulmonary Hypertension Associated Right Heart Failure
Active, not recruiting
- Right Heart Failure
- Pulmonary Hypertension
- Echocardiography
- Right heart catheterization
-
Beijing, Beijing, ChinaChina-Japan Friendship Hospital
Aug 29, 2023
Pulmonary Arterial Hypertension, Connective Tissue Diseases Trial in Mexico City
Recruiting
- Pulmonary Arterial Hypertension
- Connective Tissue Diseases
-
Mexico City, MexicoInstituto Nacional de Ciencias Médicas y Nutrición Salvador Zubi
Dec 19, 2022
Pulmonary Hypertension, Interstitial Lung Disease, Combined Pulmonary Fibrosis and Emphysema Trial (Inhaled Treprostinil)
Available
- Pulmonary Hypertension
- +2 more
- Inhaled Treprostinil
- (no location specified)
Oct 5, 2022
Pulmonary Arterial Hypertension, Idiopathic Pulmonary Arterial Hypertension, Pulmonary Arterial Hypertension Associated With
Not yet recruiting
- Pulmonary Arterial Hypertension
- +3 more
- 129Xe Hyperpolarized
-
Durham, North CarolinaDuke University Medical Center
Oct 23, 2023
Infant,Premature, Bronchopulmonary Dysplasia, Pulmonary Hypertension Trial in Salt Lake City (L-Citrulline)
Terminated
- Infant,Premature
- +2 more
-
Salt Lake City, UtahUniversity of Utah Health
Oct 11, 2022
Pulmonary Fibrosis, Pulmonary Hypertension Trial (INOpulse)
Available
- Pulmonary Fibrosis
- Pulmonary Hypertension
- INOpulse
- (no location specified)
Apr 26, 2022
Pulmonary Hypertension Trial in Lexington (MK-5475, Placebo)
Recruiting
- Pulmonary Hypertension
- MK-5475
- Placebo
-
Lexington, KentuckyLexington VA Medical Center - Cooper Division ( Site 0137)
Jan 8, 2023
Pulmonary Hypertension, Heart Failure With Reduced Ejection Fraction, Hypertension Trial in Shenyang (Pulmonary arterial
Not yet recruiting
- Pulmonary Hypertension
- +7 more
- Pulmonary arterial denervation
- Guideline-directed medical therapy (GDMT) for heart failure
-
Shenyang, Liaoning, ChinaGeneral Hospital of Northern Theater Command
Apr 10, 2023
Right Ventricle Lipid in Pulmonary Arterial Hypertension (PAH)
Not yet recruiting
- Idiopathic Pulmonary Arterial Hypertension
- +2 more
- No Intervention
- (no location specified)
Jul 14, 2022
Pulmonary Hypertension, Interstitial Lung Disease Trial (Treprostinil Palmitil Inhalation Powder, Placebo)
Not yet recruiting
- Pulmonary Hypertension
- Interstitial Lung Disease
- Treprostinil Palmitil Inhalation Powder
- Placebo
- (no location specified)
Jan 23, 2023
Heart Defects, Congenital, Pulmonary Arterial Hypertension, Genetic Testing Trial in Leuven (Genetic testing)
Recruiting
- Heart Defects, Congenital
- +2 more
- Genetic testing
-
Leuven, BelgiumUniversity Hospitals Leuven
May 17, 2022
Pulmonary Fibrosis, Pulmonary Hypertension Trial in United States (INOpulse®, Placebo, Long Term Follow Up)
Active, not recruiting
- Pulmonary Fibrosis
- Pulmonary Hypertension
- INOpulse®
- +2 more
-
Phoenix, Arizona
- +22 more
Feb 17, 2023
COPD, Pulmonary Hypertension, COPD Trial in Edegem (Inhaled Nitric Oxide 30mcg/kg IBW/hr)
Terminated
- COPD
- +2 more
- Inhaled Nitric Oxide 30mcg/kg IBW/hr
-
Edegem, BelgiumAntwerp University Hospital
Aug 9, 2022
Idiopathic Bronchiectasis and Pulmonary Hypertension
Completed
- Bronchiectasis
- Pulmonary Hypertension
- Observation of bronchiectasis with pulmonary hypertension
-
Shanghai, Shanghai, ChinaShanghai Pulmonary Hospital, Tongji University
Jan 20, 2022
Hormonal, Metabolic, and Signaling Interactions in PAH
Recruiting
- Idiopathic Pulmonary Arterial Hypertension
- +3 more
-
Nashville, TennesseeVanderbilt University Medical Center
Aug 23, 2022
Systemic Sclerosis, Pulmonary; Hypertension Trial in United States (Dimethyl Fumarate (DMF), Placebo Oral Tablet)
Terminated
- Systemic Sclerosis
- Pulmonary; Hypertension
- Dimethyl Fumarate (DMF)
- Placebo Oral Tablet
-
Denver, Colorado
- +3 more
Mar 15, 2022
HIV-Associated Pulmonary Hypertension
Completed
- HIV Infection
- +3 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Nov 8, 2021
Pulmonary Hypertension, Diastolic Heart Failure, Heart Failure With Preserved Ejection Fraction Trial in Gainesville (Nebivolol)
Terminated
- Pulmonary Hypertension
- +2 more
-
Gainesville, FloridaUniversity of Florida
Jan 19, 2022